Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.
Lammers SWM, Geurts SME, van Hellemond IEG, Swinkels ACP, Smorenburg CH, van der Sangen MJC, Kroep JR, de Graaf H, Honkoop AH, Erdkamp FLG, de Roos WK, Linn SC, Imholz ALT, Smidt ML, Vriens IJH, Tjan-Heijnen VCG. Lammers SWM, et al. Among authors: van hellemond ieg. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad092. doi: 10.1093/jncics/pkad092. JNCI Cancer Spectr. 2023. PMID: 37991939 Free PMC article. Clinical Trial.
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial.
Tjan-Heijnen VCG, van Hellemond IEG, Peer PGM, Swinkels ACP, Smorenburg CH, van der Sangen MJC, Kroep JR, De Graaf H, Honkoop AH, Erdkamp FLG, van den Berkmortel FWPJ, de Boer M, de Roos WK, Linn SC, Imholz ALT, Seynaeve CM; Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators. Tjan-Heijnen VCG, et al. Among authors: van der sangen mjc, van hellemond ieg, van den berkmortel fwpj. Lancet Oncol. 2017 Nov;18(11):1502-1511. doi: 10.1016/S1470-2045(17)30600-9. Epub 2017 Oct 12. Lancet Oncol. 2017. PMID: 29031778 Clinical Trial.
Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure.
van Hellemond IEG, Vriens IJH, Peer PGM, Swinkels ACP, Smorenburg CH, Seynaeve CM, van der Sangen MJC, Kroep JR, de Graaf H, Honkoop AH, Erdkamp FLG, van den Berkmortel FWPJ, Kitzen JJEM, de Boer M, de Roos WK, Linn SC, Imholz ALT, Tjan-Heijnen VCG; Dutch Breast Cancer Research Group (BOOG). van Hellemond IEG, et al. Among authors: van der sangen mjc, van den berkmortel fwpj. J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx074. J Natl Cancer Inst. 2017. PMID: 29546343
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure.
van Hellemond IEG, Vriens IJH, Peer PGM, Swinkels ACP, Smorenburg CH, Seynaeve CM, van der Sangen MJC, Kroep JR, de Graaf H, Honkoop AH, Erdkamp FLG, van den Berkmortel FWPJ, de Boer M, de Roos WK, Linn SC, Imholz ALT, Tjan-Heijnen VCG; Dutch Breast Cancer Research Group (BOOG). van Hellemond IEG, et al. Among authors: van der sangen mjc, van den berkmortel fwpj. Int J Cancer. 2019 Jul 1;145(1):274-283. doi: 10.1002/ijc.32093. Epub 2019 Jan 16. Int J Cancer. 2019. PMID: 30588619 Free PMC article. Clinical Trial.
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study.
van Hellemond IEG, Smorenburg CH, Peer PGM, Swinkels ACP, Seynaeve CM, van der Sangen MJC, Kroep JR, de Graaf H, Honkoop AH, Erdkamp FLG, van den Berkmortel FWPJ, de Boer M, de Roos WK, Linn SC, Imholz ALT, Tjan-Heijnen VCG; Dutch Breast Cancer Research Group (BOOG). van Hellemond IEG, et al. Among authors: van der sangen mjc, van den berkmortel fwpj. Int J Cancer. 2019 Sep 1;145(5):1325-1333. doi: 10.1002/ijc.32205. Epub 2019 Mar 4. Int J Cancer. 2019. PMID: 30748011 Free PMC article. Clinical Trial.
The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study.
de Ruijter TC, Smits KM, Aarts MJ, van Hellemond IEG, Van Neste L, de Vries B, Peer PGM, Veeck J, van Engeland M, Tjan-Heijnen VCG. de Ruijter TC, et al. Among authors: van neste l, van hellemond ieg, van engeland m. Diagn Progn Res. 2019 Oct 17;3:20. doi: 10.1186/s41512-019-0065-6. eCollection 2019. Diagn Progn Res. 2019. PMID: 31641693 Free PMC article.
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial.
van Hellemond IEG, Smorenburg CH, Peer PGM, Swinkels ACP, Seynaeve CM, van der Sangen MJC, Kroep JR, de Graaf H, Honkoop AH, Erdkamp FLG, van den Berkmortel FWPJ, de Roos WK, Linn SC, Imholz ALT, de Boer M, Tjan-Heijnen VCG; Dutch Breast Cancer Research Group (BOOG). van Hellemond IEG, et al. Among authors: van der sangen mjc, van den berkmortel fwpj. Breast Cancer Res Treat. 2020 Apr;180(3):675-685. doi: 10.1007/s10549-020-05567-9. Epub 2020 Mar 2. Breast Cancer Res Treat. 2020. PMID: 32124136 Free PMC article. Clinical Trial.
32 results